FDA Clearance Tracker · P050038-S002
ARISTA AH ABSORBABLE HEMOSTAT
Last checked: Nov 20, 2026Latest source record: May 30, 2007 (this decision)Source: openFDAMethods & limitations
Decided
May 30, 2007
Approved
Time to decision
23 days
Received May 7, 2007. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P050038-S002
- Device name
- ARISTA AH ABSORBABLE HEMOSTAT
- Applicant
- Davol, Inc.
- Applicant location
- Warwick, RI
- Received
- May 7, 2007
- Decided
- May 30, 2007
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P050038
Device type
- Device class
- Class III
- Regulation
- 21 CFR 878.4490
- Specialty
- General & Plastic SurgeryWound Care
FDA's approval statement
As written in FDA's record.
APPROVAL FOR A MANUFACTURING SITE CHANGE LOCATED AT SURGICAL TECHNOLOGIES, INC. (STI), ST. PAUL, MINNESOTA.
Source documents
Other decisions for Davol, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K261543 · Decided Sep 28, 2026 · 143 days after receipt
Device type: Mesh, Surgical, Absorbable, Abdominal Hernia (OWT) · General & Plastic Surgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.